Back to Search Start Over

Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951

Authors :
Cyril Dalmasso
Johannes L. Teepen
Johan M. Kros
Philippe Broët
Olivier Delattre
Martin J. van den Bent
Thierry Gorlia
Karima Mokhtari
Catherine Carpentier
Khê Hoang-Xuan
Jean-Yves Delattre
Judith W. M. Jeuken
Ahmed Idbaih
Mathilde C.M. Kouwenhoven
Pim J. French
M. Sanson
Neurology
Pathology
Source :
Idbaih, A, Dalmasso, C, Kouwenhoven, M, Jeuken, J, Carpentier, C, Gorlia, T, Kros, J M, French, P, Teepen, J, Broët, P, Delattre, O, Mokhtari, K, Sanson, M, Delattre, J-Y, van den Bent, M & Hoang-Xuan, K 2011, ' Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951 ', Journal of Neuro-Oncology, vol. 103, no. 2, pp. 221-30 . https://doi.org/10.1007/s11060-010-0380-9, Journal of Neuro-Oncology, Journal of Neuro-Oncology, 103, 221-30, Journal of Neuro-Oncology, 103, 2, pp. 221-30, Journal of Neuro-Oncology, 103(2), 221-30. Kluwer Academic Publishers, Journal of Neuro-Oncology, 103(2), 221-230. Kluwer Academic
Publication Year :
2011

Abstract

Despite similar morphological aspects, anaplastic oligodendroglial tumors (AOTs) form a heterogeneous clinical subgroup of gliomas. The chromosome arms 1p/19q codeletion has been shown to be a relevant biomarker in AOTs and to be perfectly exclusive from EGFR amplification in gliomas. To identify new genomic regions associated with prognosis, 60 AOTs from the EORTC trial 26951 were analyzed retrospectively using BAC-array-based comparative genomic hybridization. The data were processed using a binary tree method. Thirty-three BACs with prognostic value were identified distinguishing four genomic subgroups of AOTs with different prognosis (p

Details

Language :
English
ISSN :
0167594X
Volume :
103
Issue :
2
Database :
OpenAIRE
Journal :
Journal of Neuro-Oncology
Accession number :
edsair.doi.dedup.....8b95a9a09a9704e753d035d722cc2c59